Skip to main content
BioThera Solutions
Resources/Press/Media Kit

Everything you need to describe BioThera accurately.

Logos, science images, the founder's headshot, approved company descriptions, key facts and naming rules. All assets on this page may be used in editorial coverage of BioThera Solutions without prior approval.

Approved wording you can copy

One sentence

BioThera Solutions is an Ottawa-based biotechnology company that manufactures and characterizes extracellular vesicles (EVs, often called exosomes).

Short paragraph

BioThera Solutions is an Ottawa-based biotechnology company building a fully integrated extracellular vesicle (EV, exosome) platform, from research and intellectual property to manufacturing. Every batch is characterized in line with MISEV2023 and documented in its own Certificate of Analysis. For cosmetic applications, BioThera licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. It also supplies research-grade plant-derived EVs to laboratories. Therapeutic applications are research only.

Legal name
BioThera Solutions Inc.
Founded
2024
Headquarters
Ottawa, Ontario, Canada
Founder and CEO
Frédéric St-Denis-Bissonnette, PhD
What it makes
Characterized extracellular vesicles (EVs, exosomes); current material is plant-derived, from Aloe barbadensis
Commercial use today
Cosmetic applications, through Vesera™, a skincare company and BioThera subsidiary
Technology status
Proprietary, patent pending
Website
www.biotherasolutions.com

Frédéric St-Denis-Bissonnette, PhD

Frédéric St-Denis-Bissonnette is the Founder and CEO of BioThera Solutions. He holds a PhD with research focused on extracellular vesicle biomanufacturing and characterization, and has authored multiple peer-reviewed first-author publications. He is a named contributor to the MISEV2023 guidelines of the International Society for Extracellular Vesicles and a co-founder of the Canadian Society for Extracellular Vesicles (CanSEV). He received a 2025–2026 Fulbright Canada Short-Term Entrepreneurship Award, with a residency at MIT in April 2026.

Full profile and publications

Colours, typefaces and naming

Blue

#186FA5

Navy

#0D4A73

Teal

#1A9E8A

Black

#0A1628

Typefaces

Cormorant Garamond

Headings

Inter

Body text

Naming and accuracy

  • Write "BioThera Solutions" or "BioThera": one word, capital B and T, no hyphen. BioThera Solutions Inc. (Canada) is not affiliated with Bio-Thera Solutions, Ltd. (China).
  • Use "extracellular vesicles" or "EVs" as the main term. "Exosomes" is the common market term and can follow in parentheses.
  • The technology is "patent pending", not "patented".
  • Cosmetic products made with BioThera's material have completed Health Canada's cosmetic notification. A notification is not an approval, so please do not write "approved by Health Canada".
  • Vesera™ is a skincare company and a subsidiary of BioThera. BioThera does not sell products to consumers.
  • BioThera's work on therapeutic applications is research only. No therapeutic product exists or is offered.

Need something that is not here?

Interviews, fact checks, additional images. Responses go out within one business day.

BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing, with a process designed to scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 9B4 Canada
Add BioThera Solutions as a preferred source on Google

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.